Since 2013, diagnoses of multiple sclerosis (MS) in Finland take less time after symptom onset and treatments follow the ...

Tiziana and Renaissance will partner to accelerate clinical development and potential commercial launch of nasal foralumab.

B-cells were collected from people with and without MS, and those from patients had heightened antibody responses, ...

Four new SPMS patients not eligible for a Tiziana Life Sciences trial were dosed with foralumab nasal spray in an expanded ...

Interactions between the body's immune system and bacteria that live in the gut become disrupted in multiple sclerosis (MS), ...

Findings from the implanted scaffold led researchers to block specific inflammatory molecules, easing disease severity in a ...

Ocrevus as a first-line treatment for early relapsing MS is better at delaying disease progression than starting with a less ...

An all-new, physician-led multiple sclerosis (MS) video series designed to encourage and inspire you through expert insights, ...

Columnist Ben Hofmeister explains how songs such as "No One Is to Blame" have become part of the soundtrack of his life with MS.

An all-new, physician-led multiple sclerosis (MS) show designed to encourage and inspire you through expert insights, tips on ...

Transcript Susan Payrovi, MD Welcome to our show, “Get Tough on Multiple Sclerosis,” brought to you by Multiple Sclerosis News Today and Bionews. We are here to discuss the newest in MS care ...